Screening and Functional Analysis of TPO Gene Mutations in Patients With Congenital Hypothyroidism

Shiyi Xu1,2, Jiaying Gao1,2, Qiuting Lin1,2

  • 1Department of Endocrinology and Inborn Metabolic Diseases, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), Fuzhou, Fujian, China.

Clinical Genetics
|April 14, 2025
PubMed

Insights

Thyroid peroxidase (TPO) gene mutations are common in congenital hypothyroidism (CH). A novel TPO variant (p.K78Q) caused developmental issues and disrupted thyroid hormone synthesis gene expression in a study of CH patients.

Area of Science:

  • Genetics
  • Endocrinology
  • Developmental Biology

Background:

  • Congenital hypothyroidism (CH) is often caused by thyroid hormone synthesis disorders.
  • Thyroid peroxidase (TPO) gene mutations are the most frequent pathogenic variants identified in CH.
  • The clinical significance of some identified TPO variants remains uncertain.

Purpose of the Study:

  • To investigate the pathogenicity of a novel TPO variant of uncertain significance (VUS), p.K78Q.
  • To analyze the impact of the TPO p.K78Q variant on thyroid hormone synthesis and thyroid axis gene expression.

Main Methods:

  • Whole-exome sequencing (WES) was performed on 54 children diagnosed with CH.
  • Functional analysis of the TPO p.K78Q variant was conducted using a zebrafish model.
  • Thyroid axis gene expression was assessed following functional analysis.

Main Results:

  • The TPO p.K78Q variant was identified in the study cohort.
  • Functional analysis revealed that the TPO p.K78Q variant caused developmental defects in zebrafish.
  • The variant disrupted thyroid axis gene expression, leading to decreased expression of tg, dio1, dio2, trβ, nis, ttr and increased expression of tshβ, trα.

Conclusions:

  • The novel TPO p.K78Q variant is pathogenic and contributes to CH.
  • The findings clarify the significance of a previously uncertain TPO variant.
  • This study highlights the importance of functional analysis in diagnosing CH caused by TPO mutations.